The Department of Veterans Affairs's NAICS 325412 (Pharmaceutical Preparation Manufacturing) market: incumbents, spending trend, set-asides and open solicitations — from FY2026 USAspending awards and live SAM.gov notices.
Contract data as of Oct 18, 2026 (USAspending) · recent coverage verified weekly
| Quarter | Awards | Obligated | Change |
|---|---|---|---|
| Q1 FY2026 | 337 | $3.8B | — |
| Q2 FY2026 | 338 | $3.5B | -9% |
| Q3 FY2026 | 244 | $3.8B | +11% |
| Q4 FY2026 | 193 | $2.4B | -37% |
Federal fiscal quarters (Q1 = Oct–Dec). Awards are counted in the quarter they start; obligations are the award's obligated amount.
| # | Contractor | Obligated | Share |
|---|---|---|---|
| 1 | MCKESSON CORPORATION | $13.2B | 97.7% |
| 2 | EXELAN PHARMACEUTICALS INC | $99.1M | 0.7% |
| 3 | NOVARTIS SANIERUNGSSTIFTUNG | $40.5M | 0.3% |
| 4 | LANTHEUS HOLDINGS, INC. | $28.8M | 0.2% |
| 5 | CARDINAL HEALTH, INC. | $25.8M | 0.2% |
Registrations are rolled up to their corporate parent (USAspending parent UEI), so a company with several SAM registrations ranks once.
| Set-aside type | Obligated | Share |
|---|---|---|
| Small business set-aside | $11.3M | 20.8% |
| 8(a) | $0 | 0.0% |
| SDVOSB | $17K | 0.0% |
| WOSB / EDWOSB | $0 | 0.0% |
| HUBZone | $0 | 0.0% |
| No set-aside (full & open) | $43.1M | 79.2% |
Share of obligations on awards whose set-aside type is recorded — 0% of this market's dollars. Most USAspending bulk-archive records leave the field blank, so blank awards are excluded rather than counted as full & open.
Links open the notice on SAM.gov.
Source: USAspending.gov contract awards (prime awards with a start date from Oct 1, 2025 through Sep 30, 2026), SAM.gov contract opportunities, and SBA size standards. Recompetes are contracts whose final end date — options included — falls in the next 12 months. Figures are recomputed when a new USAspending load lands. See our data sources.